Keyword: Catalent

News

J&J Signs two new Covid-Vaccine Pacts

05.05.2020 -

As part of a plan to establish a network of manufacturing partners to help boost capacity ahead of a potential FDA approval of a Covid-19 vaccine, US healthcare giant...

News

Catalent Acquires MaSTherCell Global

14.02.2020 - US contract development and manufacturing organization Catalent has acquired MaSTherCell Global for $315 million cash, boosting its cell and gene therapy capabilities. The New...

News

Catalent Appoints Ricci Whitlow as President of Clinical Supply Services

29.01.2020 - Catalent has appointed Ricci Whitlow as president of its Clinical Supply Services business unit. She succeeds Paul Hegwood, who will retire in March 2020. Whitlow has over 25 years...

Strategy & Management

Experts Statements: Jessica Cao, Catalent

05.09.2019 - The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...

Strategy & Management

The Pharma CDMO Challenge

05.09.2019 - The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...

News

Catalent Buys Facilities in US and Italy

08.07.2019 - Catalent Biologics, through its Paragon Gene Therapy business, has agreed to assume the leases to two Novavax facilities in Maryland, USA. The move, said Novavax, will reduce its...

News

Catalent Buying BMS Site in Italy

24.06.2019 - Continuing a buying spree that has added adding biologics and gene therapy capabilities to its manufacturing repertoire, California-based US drug developer Catalent is buying a...

News

Catalent Expands German Softgel Output

26.04.2019 - US drug developer Catalent has announced plans to expand its integrated turnkey softgel capabilities at Eberbach, Germany, at a cost of $14 million up to 2020. The expansion...